Skip to content

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen, Sys Stybe Johansen, Sczabolz Lehel, Kristían Línnet, Claus Svarer, David Erritzøe, Brice Ozenne, Gitte M. Knudsen

Neuropsychopharmacology January 26, 2019 DOI: 10.1038/s41386-019-0324-9 (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 8
Population Healthy volunteers
Intervention Psilocybin
Dose 3-30 mg
Topics Psilocybin Serotonin
Keywords Hallucinogen Binding potential Pharmacology
Citations 505
Key findings Psilocybin intake leads to significant 5-HT2AR occupancy in the human brain, and both psilocin plasma levels and 5-HT2AR occupancy are closely associated with subjective intensity ratings.

Abstract

The main psychedelic component of magic mushrooms is psilocybin, which shows promise as a treatment for depression and other mental disorders. Psychedelic effects are believed to emerge through stimulation of serotonin 2A receptors (5-HT2ARs) by psilocybin's active metabolite, psilocin. We here report for the first time the relationship between intensity of psychedelic effects, cerebral 5-HT2AR occupancy and plasma levels of psilocin in humans. Eight healthy volunteers underwent positron emission tomography (PET) scans with the 5-HT2AR agonist radioligand [11C]Cimbi-36: one at baseline and one or two additional scans on the same day after a single oral intake of psilocybin (3-30 mg). 5-HT2AR occupancy was calculated as the percent change in cerebral 5-HT2AR binding relative to baseline. Subjective psychedelic intensity and plasma psilocin levels were measured during the scans. Relations between subjective intensity, 5-HT2AR occupancy, and plasma psilocin levels were modeled using non-linear regression. Psilocybin intake resulted in dose-related 5-HT2AR occupancies up to 72%; plasma psilocin levels and 5-HT2AR occupancy conformed to a single-site binding model. Subjective intensity was correlated with both 5-HT2AR occupancy and psilocin levels as well as questionnaire scores. We report for the first time that intake of psilocybin leads to significant 5-HT2AR occupancy in the human brain, and that both psilocin plasma levels and 5-HT2AR occupancy are closely associated with subjective intensity ratings, strongly supporting that stimulation of 5-HT2AR is a key determinant for the psychedelic experience. Important for clinical studies, psilocin time-concentration curves varied but psilocin levels were closely associated with psychedelic experience.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Psilocybin produced dose-related 5-HT2A receptor occupancy up to 72%, and both occupancy and plasma psilocin levels correlated with subjective psychedelic intensity.

    Synthesized

Comparable studies

Other observational and cohort studies on serotonin, most cited first.

Study Year Design Participants
Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users 1998 Observational cohort
Dynamic coupling of whole-brain neuronal and neurotransmitter systems Healthy humans 2020 Observational study
The Serotonin System and Spiritual Experiences Normal male subjects, ages 20-45 years 2003 Observational cohort n = 15
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Healthy human participants 2018 Observational study with computational modeling
Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome. Rat 1986 Observational study

Citations in the library

Cited by 439

and 434 more in the library

Cites 23

and 18 more in the library

Explore topics